Category Archives: Antibody Drug Conjugates

Meet Clay Siegall, the genius behind antibody drug conjugates

One of the most innovative areas in cancer research, in the last few decades, has been the advent of targeted cancer therapies. This term broadly refers to a class of drugs that use various means of specifically targeting malignant tissues, rather than systemically releasing large amounts of cytotoxins into the patient’s system. These drugs have […]